🇺🇸 FDA
Patent

US 11390921

Determining WT-1 specific T cells and WT-1 specific T cell receptors (TCRs)

granted A61KA61K2039/804A61K40/11

Quick answer

US patent 11390921 (Determining WT-1 specific T cells and WT-1 specific T cell receptors (TCRs)) held by Adaptive Biotechnologies Corporation expires Mon Jul 14 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Adaptive Biotechnologies Corporation
Grant date
Tue Jul 19 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 14 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K2039/804, A61K40/11, A61K40/32, A61K40/4243